Related Experiment Video
Updated: Jun 24, 2026

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates
Published on: January 27, 2019
Increased CXCL-13 levels in human African trypanosomiasis meningo-encephalitis
Bertrand Courtioux1, Lynda Pervieux, Gedeao Vatunga
1Institut de Neurologie Tropicale, Université de Limoges, Limoges, France. bertrand.courtioux@unilim.fr
Insights
Levels of CXCL-13 in cerebrospinal fluid (CSF) increased with the progression of Human African Trypanosomiasis (HAT) meningoencephalitis. This chemokine may aid in diagnosing HAT and monitoring disease severity.
Area of Science:
- Neuroimmunology
- Infectious Diseases
- Biomarker Discovery
Background:
- Human African Trypanosomiasis (HAT) meningoencephalitis presents diagnostic challenges.
- The B-cell attracting chemokine CXCL-13 is implicated in B-cell trafficking and immunoglobulin M (IgM) production.
Purpose of the Study:
- To investigate the role of CXCL-13 in diagnosing HAT meningoencephalitis.
- To assess CXCL-13 as a potential marker for disease staging and severity.
Main Methods:
- CXCL-13 levels were measured using ELISA in paired serum and cerebrospinal fluid (CSF) samples from 26 HAT patients and 16 controls.
- Results were correlated with established stage determination markers and indicators of intrathecal IgM synthesis.
Main Results:
- Elevated serum CXCL-13 levels correlated with the presence of trypanosomes in CSF.
- Significantly increased CXCL-13 levels were observed in CSF, correlating with all standard stage markers and intrathecal IgM synthesis.
Conclusions:
- CSF CXCL-13 levels show a significant increase during HAT progression.
- CXCL-13 warrants further investigation as a diagnostic and prognostic biomarker for HAT meningoencephalitis in larger cohort studies.
Objectives:
To determine the role of the B-cell attracting chemokine CXCL-13, which may initiate B-cell trafficking and IgM production in diagnosing HAT meningo-encephalitis.
Methods:
We determined CXCL-13 levels by ELISA on paired sera and CSF of 26 patients from Angola and of 16 controls (six endemic and ten non-endemic). Results were compared to standard stage determination markers and IgM intrathecal synthesis.
Results:
CXCL-13 levels in patients' sera had a median value of 386.6 pg/ml and increased levels were associated with presence of trypanosomes in the CSF but not with other stage markers. CXCL-13 levels in patients' CSF had a median value of 80.9 pg/ml and increased levels were associated with all standard stage determination markers and IgM intrathecal synthesis.
Conclusion:
CXCL-13 levels in CSF increased significantly during the course of HAT. Hence the value of CXCL-13 for diagnosis, follow-up or as a marker of disease severity should be tested in a well-defined cohort study.
Related Concept Videos
American Trypanosomiasis
Arboviral Encephalitis
Toxoplasmosis
Encephalitis l: Introduction
Cryptococcal Meningitis
Encephalitis ll: Pathophysiology

